Page 122 - Forbes - USA (December 2019)

HEALTHCARE JOEY AZOFEIFA, 29
CHLOE ALPERT, 28
Cofounder, Medinas

Founder, Arpeggio Bio
ERICA BARNELL, 29
Cofounders, Geneoscopy
DOUG BERNSTEIN, 29;
JAIME QUINTERNO, 29
Cofounders, PECA Labs
CATHARINE BOWMAN, 21
Board director,
Alberta Lymphedema Association
120
JEAN FAN, 28
Postdoctoral fellow, Harvard University
MARK FAYNGERSH, 27;
ILYA VAKHUTINSKY, 27
Cofounders, CareSwitch
EVAN FEINBERG, 28;
BEN SKLAROFF, 27
Cofounders, Genesis Therapeutics
SAMANTHA GERSON, 26
Founder, UnBroken
ANNETTE GROTHEER, 29
Founder, The Shop Docs
LEA HACHIGIAN, 29;
TOMASZ KULA, 29
Cofounders, TScan Therapeutics
BOBBY BROOKE HERRERA, 29
Cofounder, E25Bio
RUMEN HRISTOV, 26;
ZACHARY KABELAC, 29
Cofounders, Emerald Innovations
ZAAMIN HUSSAIN, 26
Clinical researcher, Harvard University
JOE KAHN, 24;
YASYF MOHAMEDALI, 24
Cofounders, Karuna Health
ARTHUR KUAN, 29
CEO, Cold Genesys
RAINIER MALLOL, 28
Cofounder, AIME
ROB MANNINO, 28;
ERIKA TYBURSKI, 29
Cofounders, Sanguina
ASHLEY MOY, 25;
JASON TROUTNER, 26
Cofounders, Cast21
JANEL NOUR-OMID, 27
Cofounder, Vitalacy
KUNAL PARIKH, 29
Research associate,
ARTHUR KUAN, 29 Johns Hopkins University
BRYAN PATENAUDE, 29
CEO, C OL D G E N ESYS
Assistant professor,
Johns Hopkins University
Arthur Kuan is going viral. He’s the CEO of Santa Ana, Cal- VIJAY RAMANI, 29
ifornia, biotech company Cold Genesys, which genetical- Principal investigator, UCSF
ly modifies viruses to attack cancer and, as an added benefit, SANA RAOOF, 29

bolsters your immune system against it. The former venture Researcher, Harvard University
investor encountered Cold Genesys as a founding member ZACHARIAH REITANO, 28
Cofounder, RO
at Hong Kong healthcare fund Ally Bridge Group. Fascinat-
EVA SADEJ, 29
ed by the science, Kuan, who holds a master’s in biotechnolo-
Founder, Floss Bar
gy from Johns Hopkins, joined Cold Genesys as COO. When
JESSICA SCHLEIDER, 29
founder Alex Yeung retired in 2016, Kuan took over. He’s since Assistant professor,
launched clinical trials of the biotech’s bladder cancer treat- Stony Brook University
ment and has inked a partnership to test its effectiveness with DEAN TRAVERS, 23;

SCOTT XIAO, 21
Merck’s immunotherapy drug Keytruda. Kuan says, “I’ve done Cofounders, Luminopia
a good job turning this science story into a real business con-
CAMERON TURTLE, 29
cept.” In March he closed a $22 million series-C round with Chief business officer,

ORI Capital and Lepu Medical, which has the China license Eidos Therapeutics
for its products. —Alex Knapp, Leah Rosenbaum CAROLYN YARINA, 29
Cofounder, Sisu Global
JUDGES: DENISE HINTON, CHIEF SCIENTIST, FDA; TREVOR MARTIN, CEO, MAMMOTH BIOSCIENCES (UNDER 30 CLASS OF 2019);
ROBERT NELSEN, PARTNER, ARCH VENTURE PARTNERS; HELEN TORLEY, CEO, HALOZYME.
ARTHUR KUAN WEARS AN ISAIA WOOL TOPCOAT, DENIM SHIRT AND FLORAL PANTS AND A RICHARD JAMES STRIPED TIE.

F O R B E S . C O M D E C E M B E R 3 1 , 2 0 1 9